Results for rating scale translation from English to Icelandic

scale
gildi

scale:
skali: @ info: tooltip

auto scale
horn

scale 100%
hlutfall 100%

scale & & crop
teygja & & sníða af

horizontal scale
láréttur skali

selection: scale
val: skala

beaufort scale bft
beaufort skali bft

scale this length...
velja & lengd...

patient-reported outcome - gastrointestinal symptoms rating scale
niðurstöður sem tilkynntar voru af sjúklingum- matskvarði fyrir einkenni frá meltingarvegi

the adhd rating scale is a measure of the core symptoms of adhd.
ofvirknikvarðinn (the adhd rating scale) er mælikvarði á grunneinkenni adhd.

insulin scale insulin window
insúlínkvarði insúlíngluggi

subjects had a median cumulative illness rating scale (cirs) score of 8.
einstaklingarnir voru með miðgildi heilsufarseinkenna (cumulative illness rating scale, cirs) 8.

relief of the symptoms of gad as reflected by the hamilton anxiety rating scale (ham-a) was observed by week 1.
linun einkenna kvíðaröskunar skilgreint samkvæmt „hamilton anxiety rating scale (ham-a)“ kom fram á 1. viku.

in the 24-week double- blind study, the most commonly observed symptoms (skin irritation rating scale) with rivastigmine
Í 24 vikna tvíblindu rannsókninni voru algengustu einkennin sem komu fram (húðertingarmælikvarði) við notkun rivastigmin

reduction in hs-related skin pain was assessed using a numeric rating scale in patients who entered the study with an initial baseline score of 3 or greater on a 11 point scale.
minnkun á verk í húð tengdum graftarmyndandi svitakirtlabólgu var metin með tölulegum kvarða með 11 stigum, hjá sjúklingum sem voru með upphafsskor 3 eða hærra þegar þeir komu inn í rannsóknina

in two 24-week double-blind, placebo-controlled clinical trials, skin reactions were measured at each visit using a skin irritation rating scale.
Í tveimur 24 vikna tvíblindum klínískum samanburðarrannsóknum með lyfleysu voru húðviðbrögð metin í hverri heimsókn samkvæmt húðertingarmælikvarða.

study results showed statistically significant superiority for all three sycrest doses in improving the young mania rating scale (ymrs) total score as measured by the change from baseline to day 21, as compared with placebo.
niðurstöður rannsóknarinnar sýndu tölfræðilega marktæka yfirburði við að bæta heildarstig samkvæmt ymrs miðað við breytingu frá grunngildi til 21. dags fyrir alla þrjá sycrest skammtana samanborið við lyfleysu.

in this study, the primary measure of efficacy was the change from baseline in the total score of the unified parkinson’s disease rating scale (updrs, parts i-iii).
Í þessari rannsókn var mat á verkun fyrst og fremst breyting frá upphaflegum heildarstigafjölda á “unified parkinson’s disease rating scale” (updrs, hlutum i-iii).

the mean change from baseline in the restless legs syndrome rating scale (irls) and the clinical global impression-improvement (cgi-i) were the primary efficacy outcome measures.
meginmælikvarði á verkun var meðalbreyting frá upphafi á irls kvarðanum (restless legs syndrome rating scale) og cgi-i (clinical global impression-improvement).